Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 252

1.

Reduced skeletal muscle expression of mitochondrial derived peptides humanin and MOTS-C and Nrf2 in chronic kidney disease.

Liu C, Gidlund EK, Witasp A, Qureshi AR, Söderberg M, Thorell A, Nader GA, Barany P, Stenvinkel P, von Walden F.

Am J Physiol Renal Physiol. 2019 Aug 21. doi: 10.1152/ajprenal.00202.2019. [Epub ahead of print]

PMID:
31432706
2.

The cholinergic anti-inflammatory pathway in resistant hypertension treated with renal denervation.

Hilderman M, Qureshi AR, Abtahi F, Witt N, Jägren C, Olbers J, Delle M, Lindecrantz K, Bruchfeld A.

Mol Med. 2019 Aug 15;25(1):39. doi: 10.1186/s10020-019-0097-y.

3.

Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease.

Dai L, Watanabe M, Qureshi AR, Mukai H, Machowska A, Heimbürger O, Barany P, Lindholm B, Stenvinkel P.

Eur J Intern Med. 2019 Aug 8. pii: S0953-6205(19)30270-5. doi: 10.1016/j.ejim.2019.07.035. [Epub ahead of print]

PMID:
31402276
4.

Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine measurements project.

Runesson B, Trevisan M, Iseri K, Qureshi AR, Lindholm B, Barany P, Elinder CG, Carrero JJ.

Nephrol Dial Transplant. 2019 Jul 30. pii: gfz142. doi: 10.1093/ndt/gfz142. [Epub ahead of print]

PMID:
31361316
5.

Early Vascular Ageing and Cellular Senescence in Chronic Kidney Disease.

Dai L, Qureshi AR, Witasp A, Lindholm B, Stenvinkel P.

Comput Struct Biotechnol J. 2019 Jun 18;17:721-729. doi: 10.1016/j.csbj.2019.06.015. eCollection 2019. Review.

6.

Chemerin inhibits vascular calcification through ChemR23 and is associated with lower coronary calcium in chronic kidney disease.

Carracedo M, Witasp A, Qureshi AR, Laguna-Fernandez A, Brismar T, Stenvinkel P, Bäck M.

J Intern Med. 2019 Jun 13. doi: 10.1111/joim.12940. [Epub ahead of print]

PMID:
31197872
7.

Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study.

Pei M, Aguiar R, Pagels AA, Heimbürger O, Stenvinkel P, Bárány P, Medin C, Jacobson SH, Hylander B, Lindholm B, Qureshi AR.

BMC Nephrol. 2019 Apr 29;20(1):144. doi: 10.1186/s12882-019-1318-x.

8.

Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients.

Chen Z, Qureshi AR, Brismar TB, Ripsweden J, Haarhaus M, Barany P, Heimburger O, Lindholm B, Stenvinkel P.

BMC Nephrol. 2019 Feb 18;20(1):59. doi: 10.1186/s12882-019-1235-z.

9.

Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project.

Runesson B, Qureshi AR, Xu H, Gasparini A, Lindholm B, Barany P, Elinder CG, Carrero JJ.

PLoS One. 2019 Jan 16;14(1):e0209440. doi: 10.1371/journal.pone.0209440. eCollection 2019.

10.

Parkinson's pain is more aching and interfering with social life in Caucasians compared to Indians.

Rana AQ, Qureshi ARM, Rizvi SFH, Mohiuddin MM, Hussain Syed B, Sarfraz Z, Rana R.

Int J Neurosci. 2019 Aug;129(8):746-753. doi: 10.1080/00207454.2019.1566232. Epub 2019 Mar 20.

PMID:
30616495
11.

Health-related quality of life in peritoneal dialysis patients: A narrative review.

Aguiar R, Pei M, Qureshi AR, Lindholm B.

Semin Dial. 2019 Sep;32(5):452-462. doi: 10.1111/sdi.12770. Epub 2018 Dec 21. Review.

PMID:
30575128
12.

New Algorithm for the Management of Orbital Blowout Fracture Based on Prospective Study.

Alinasab B, Borstedt KJ, Rudström R, Ryott M, Qureshi AR, Beckman MO, Stjärne P.

Craniomaxillofac Trauma Reconstr. 2018 Dec;11(4):285-295. doi: 10.1055/s-0038-1641714. Epub 2018 May 1.

PMID:
30574272
13.

Inverse J-shaped relation between coronary arterial calcium density and mortality in advanced chronic kidney disease.

Mukai H, Dai L, Chen Z, Lindholm B, Ripsweden J, Brismar TB, Heimbürger O, Barany P, Qureshi AR, Söderberg M, Bäck M, Stenvinkel P.

Nephrol Dial Transplant. 2018 Dec 7. doi: 10.1093/ndt/gfy352. [Epub ahead of print]

PMID:
30534995
14.

Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease.

Feldreich T, Nowak C, Fall T, Carlsson AC, Carrero JJ, Ripsweden J, Qureshi AR, Heimbürger O, Barany P, Stenvinkel P, Vuilleumier N, Kalra PA, Green D, Ärnlöv J.

J Nephrol. 2019 Feb;32(1):111-119. doi: 10.1007/s40620-018-0556-5. Epub 2018 Nov 29.

15.

Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients.

Boltenstål H, Qureshi AR, Behets GJ, Lindholm B, Stenvinkel P, D'Haese PC, Haarhaus M.

Calcif Tissue Int. 2019 Feb;104(2):214-223. doi: 10.1007/s00223-018-0491-4. Epub 2018 Nov 7.

PMID:
30406279
16.

Effects of acute fructose loading on levels of serum uric acid-a pilot study.

Olofsson C, Anderstam B, Bragfors-Helin AC, Eriksson M, Qureshi AR, Lindholm B, Hilding A, Wiczkowski W, Orsini N, Stenvinkel P, Rajamand Ekberg N.

Eur J Clin Invest. 2019 Jan;49(1):e13040. doi: 10.1111/eci.13040. Epub 2018 Nov 16.

PMID:
30368775
17.

Peritonitis: Episode Sequence, Microbiological Variation, Risk Factors and Clinical Outcomes in a North China Peritoneal Dialysis Center.

Hu S, Ming P, Qureshi AR, Lindholm B, Bo Y, Yang H.

Kidney Blood Press Res. 2018;43(5):1573-1584. doi: 10.1159/000494443. Epub 2018 Oct 22.

18.

Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study.

Levin A, Nair D, Qureshi AR, Bárány P, Heimburger O, Anderstam B, Stenvinkel P, Bruchfeld A, Ungerstedt JS.

Nephron. 2018;140(4):249-256. doi: 10.1159/000492500. Epub 2018 Sep 25.

PMID:
30253414
19.

Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis.

Rana AQ, Qureshi AR, Siddiqui O, Sarfraz Z, Rana R, Shtilbans A.

J Neurol. 2019 Sep;266(9):2093-2102. doi: 10.1007/s00415-018-9049-7. Epub 2018 Sep 20. Review.

PMID:
30238268
20.

Negative impact of severity of pain on mood, social life and general activity in Parkinson's disease.

Rana AQ, Qureshi ARM, Haris A, Danish MA, Furqan MS, Shaikh O, Sarfraz Z, Rana R.

Neurol Res. 2018 Dec;40(12):1054-1059. doi: 10.1080/01616412.2018.1517852. Epub 2018 Sep 15.

PMID:
30221591
21.

Younger patients and smokers report a higher level of pain after knee arthroscopy: a clinical and experimental study including synovial metabolism.

Berglund L, Stålman A, Dungner E, Qureshi AR, Kumlin M, Felländer-Tsai L.

Knee Surg Sports Traumatol Arthrosc. 2019 Feb;27(2):471-477. doi: 10.1007/s00167-018-5125-x. Epub 2018 Sep 7.

22.

Comprehensive Examination of Therapies for Pain in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Qureshi AR, Rana AQ, Malik SH, Rizvi SFH, Akhter S, Vannabouathong C, Sarfraz Z, Rana R.

Neuroepidemiology. 2018;51(3-4):190-206. doi: 10.1159/000492221. Epub 2018 Aug 28.

23.

Prospective Randomized Controlled Pilot Study on Orbital Blowout Fracture.

Alinasab B, Borstedt KJ, Rudström R, Ryott M, Qureshi AR, Stjärne P.

Craniomaxillofac Trauma Reconstr. 2018 Sep;11(3):165-171. doi: 10.1055/s-0038-1641170. Epub 2018 Apr 2.

24.

Osteoarthritis Increases Paresthestic and Akathisic Pain, Anxiety Case-ness, and Depression Severity in Patients With Parkinson's Disease.

Rana AQ, Qureshi AR, Akhter S, Ingar Y, Ayub A, Abdullah I, Madhosh O, Sarfraz Z, Rana MB, Rana R.

Front Neurol. 2018 Jun 13;9:409. doi: 10.3389/fneur.2018.00409. eCollection 2018.

25.

Inflammation down-regulates CYP3A4-catalysed drug metabolism in hemodialysis patients.

Molanaei H, Qureshi AR, Heimbürger O, Lindholm B, Diczfalusy U, Anderstam B, Bertilsson L, Stenvinkel P.

BMC Pharmacol Toxicol. 2018 Jun 25;19(1):33. doi: 10.1186/s40360-018-0221-6.

26.

Serum albumin, inflammation, and nutrition in end-stage renal disease: C-reactive protein is needed for optimal assessment.

Mukai H, Villafuerte H, Qureshi AR, Lindholm B, Stenvinkel P.

Semin Dial. 2018 Sep;31(5):435-439. doi: 10.1111/sdi.12731. Epub 2018 Jun 21.

PMID:
29926516
27.

Vital Sign Variations with Complications during Dialysis among End-Stage Renal Disease Patients.

Qureshi AR, Durrani N, Asif N.

J Coll Physicians Surg Pak. 2018 Jun;28(6):431-435. doi: 10.29271/jcpsp.2018.06.431.

PMID:
29848417
28.

Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients.

Carrero JJ, Cabezas-Rodríguez I, Qureshi AR, Floege J, Ketteler M, London G, Locatelli F, Memmos D, Goldsmith D, Ferreira A, Nagy J, Teplan V, Martínez-Salgado C, Fernández-Martín JL, Zoccali C, Cannata-Andia JB; COSMOS group.

Nefrologia. 2018 Sep - Oct;38(5):520-527. doi: 10.1016/j.nefro.2018.02.009. Epub 2018 Jun 11. English, Spanish.

29.

Restrictive lung disorder is common in patients with kidney failure and associates with protein-energy wasting, inflammation and cardiovascular disease.

Mukai H, Ming P, Lindholm B, Heimbürger O, Barany P, Anderstam B, Stenvinkel P, Qureshi AR.

PLoS One. 2018 Apr 27;13(4):e0195585. doi: 10.1371/journal.pone.0195585. eCollection 2018.

30.

Decreased sleep quality in Parkinson's patients is associated with higher anxiety and depression prevalence and severity, and correlates with pain intensity and quality.

Rana AQ, Qureshi ARM, Shamli Oghli Y, Saqib Y, Mohammed B, Sarfraz Z, Rana R.

Neurol Res. 2018 Aug;40(8):696-701. doi: 10.1080/01616412.2018.1462880. Epub 2018 Apr 17.

PMID:
29663852
31.

Effects of Probiotic Supplementation on Trimethylamine-N-Oxide Plasma Levels in Hemodialysis Patients: a Pilot Study.

Borges NA, Stenvinkel P, Bergman P, Qureshi AR, Lindholm B, Moraes C, Stockler-Pinto MB, Mafra D.

Probiotics Antimicrob Proteins. 2019 Jun;11(2):648-654. doi: 10.1007/s12602-018-9411-1.

PMID:
29651635
32.

Lung Dysfunction and Mortality in Patients with Chronic Kidney Disease.

Mukai H, Ming P, Lindholm B, Heimbürger O, Barany P, Stenvinkel P, Qureshi AR.

Kidney Blood Press Res. 2018;43(2):522-535. doi: 10.1159/000488699. Epub 2018 Mar 29.

33.

Lower serum calcium is independently associated with CKD progression.

Janmaat CJ, van Diepen M, Gasparini A, Evans M, Qureshi AR, Ärnlöv J, Barany P, Elinder CG, Rotmans JI, Vervloet M, Dekker FW, Carrero JJ.

Sci Rep. 2018 Mar 26;8(1):5148. doi: 10.1038/s41598-018-23500-5.

34.

Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.

Mukai H, Svedberg O, Lindholm B, Dai L, Heimbürger O, Barany P, Anderstam B, Stenvinkel P, Qureshi AR.

Nephrol Dial Transplant. 2019 Mar 1;34(3):442-448. doi: 10.1093/ndt/gfx371.

PMID:
29378035
35.

The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease.

Alves FC, Sun J, Qureshi AR, Dai L, Snaedal S, Bárány P, Heimbürger O, Lindholm B, Stenvinkel P.

PLoS One. 2018 Jan 3;13(1):e0190410. doi: 10.1371/journal.pone.0190410. eCollection 2018.

36.

Clinical global assessment of nutritional status as predictor of mortality in chronic kidney disease patients.

Dai L, Mukai H, Lindholm B, Heimbürger O, Barany P, Stenvinkel P, Qureshi AR.

PLoS One. 2017 Dec 6;12(12):e0186659. doi: 10.1371/journal.pone.0186659. eCollection 2017.

37.

Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time.

van Craenenbroeck AH, Bragfors-Helin AC, Qureshi AR, Lindholm B, Sjöberg B, Anderstam B, Heimburger O, Stenvinkel P, Bárány P.

Kidney Blood Press Res. 2017;42(5):877-885. doi: 10.1159/000484537. Epub 2017 Nov 22.

38.

Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?

Jankowska M, Haarhaus M, Qureshi AR, Lindholm B, Evenepoel P, Stenvinkel P.

Kidney Int Rep. 2017 Jan 10;2(3):481-485. doi: 10.1016/j.ekir.2017.01.001. eCollection 2017 May.

39.

The impact of body mass index (BMI) variation on mortality of incident elderly patients on peritoneal dialysis: a joint model analysis.

Franco MRG, Colugnati FAB, Qureshi AR, Divino-Filho JC, Fernandes NMDS.

J Bras Nefrol. 2017 Jul-Sep;39(3):267-274. doi: 10.5935/0101-2800.20170050. English, Portuguese.

40.

Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease-confounding and modifying effects of cardiovascular disease, body composition and inflammation.

Nilsson E, Cao Y, Lindholm B, Ohyama A, Carrero JJ, Qureshi AR, Stenvinkel P.

Nephrol Dial Transplant. 2018 Jun 1;33(6):971-977. doi: 10.1093/ndt/gfx215.

PMID:
28992321
41.

Pregnancy-associated plasma protein-A predicts survival in end-stage renal disease-confounding and modifying effects of cardiovascular disease, body composition and inflammation.

Nilsson E, Cao Y, Lindholm B, Ohyama A, Carrero JJ, Qureshi AR, Stenvinkel P.

Nephrol Dial Transplant. 2017 Oct 1;32(10):1776. doi: 10.1093/ndt/gfx266. No abstract available.

PMID:
28967965
42.

Incident elderly patients on peritoneal dialysis: Epidemiological characteristics and modality impact on survival time.

Franco MRG, Bastos MG, Qureshi AR, Schreider A, Bastos KA, Divino-Filho JC, Fernandes NMS.

Saudi J Kidney Dis Transpl. 2017 Jul-Aug;28(4):782-791.

43.

Ophthalmological Features of Machado-Joseph Disease.

Rana AQ, Qureshi DT, Morshed M, Kachhvi ZM, Rana MA, Qureshi ARM.

J Coll Physicians Surg Pak. 2016 Nov;26(11):137-139. doi: 227.

PMID:
28666509
44.

Disability from pain directly correlated with depression in Parkinson's disease.

Rana AQ, Qureshi ARM, Rahman N, Mohammed A, Sarfraz Z, Rana R.

Clin Neurol Neurosurg. 2017 Sep;160:1-4. doi: 10.1016/j.clineuro.2017.05.022. Epub 2017 May 30.

PMID:
28600960
45.

Prospective study on ocular motility limitation due to orbital muscle entrapment or impingement associated with orbital wall fracture.

Alinasab B, Qureshi AR, Stjärne P.

Injury. 2017 Jul;48(7):1408-1416. doi: 10.1016/j.injury.2017.04.039. Epub 2017 Apr 21.

PMID:
28499464
46.

Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.

Szummer K, Gasparini A, Eliasson S, Ärnlöv J, Qureshi AR, Bárány P, Evans M, Friberg L, Carrero JJ.

J Am Heart Assoc. 2017 Mar 1;6(3). pii: e004925. doi: 10.1161/JAHA.116.004925.

47.

Dialysis access, infections, and hospitalisations in unplanned dialysis start patients: results from the OPTiONS study.

Machowska A, Alscher MD, Vanga SR, Koch M, Aarup M, Qureshi AR, Lindholm B, Rutherford P.

Int J Artif Organs. 2017 Mar 16;40(2):48-59. doi: 10.5301/ijao.5000557. Epub 2017 Feb 11.

PMID:
28218354
48.

CDKN2A/p16INK4a expression is associated with vascular progeria in chronic kidney disease.

Stenvinkel P, Luttropp K, McGuinness D, Witasp A, Qureshi AR, Wernerson A, Nordfors L, Schalling M, Ripsweden J, Wennberg L, Söderberg M, Bárány P, Olauson H, Shiels PG.

Aging (Albany NY). 2017 Feb 9;9(2):494-507. doi: 10.18632/aging.101173.

49.

Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.

Lundström UH, Gasparini A, Bellocco R, Qureshi AR, Carrero JJ, Evans M.

BMC Nephrol. 2017 Feb 10;18(1):59. doi: 10.1186/s12882-017-0473-1.

50.

Offering Patients Therapy Options in Unplanned Start (OPTiONS): Implementation of an educational program is feasible and effective.

Machowska A, Alscher MD, Vanga SR, Koch M, Aarup M, Qureshi AR, Lindholm B, Rutherford P.

BMC Nephrol. 2017 Jan 13;18(1):18. doi: 10.1186/s12882-016-0419-z.

Supplemental Content

Loading ...
Support Center